Literature DB >> 1587512

Assessment of risk behaviors for HIV infection among psychiatric inpatients.

J Volavka1, A Convit, J O'Donnell, R Douyon, C Evangelista, P Czobor.   

Abstract

A 13-item questionnaire was constructed to assess risk factors for HIV infection among 476 patients newly admitted over a one-year period to a state psychiatric hospital in New York City. Because psychopathology can affect patients' self-reports, the validity of the instrument was established by HIV antibody tests in a subset of 352 patients. Results of the questionnaire indicated that the 352 patients were almost equally divided between the high-risk and low-risk categories. HIV seroprevalence was .6 percent among the low-risk patients, but 14.4 percent among the high-risk patients. The findings suggest that a screening program to detect HIV-positive patients should be undertaken in this population, that it should be focused on the high-risk subgroup, and that the questionnaire can be used to define that subgroup. However, results of the study may not generalize to other geographic areas.

Entities:  

Mesh:

Year:  1992        PMID: 1587512     DOI: 10.1176/ps.43.5.482

Source DB:  PubMed          Journal:  Hosp Community Psychiatry        ISSN: 0022-1597


  13 in total

1.  The HIV Epidemic Among Individuals with Mental Illness in the United States.

Authors:  Sheri D Weiser; William R Wolfe; David R Bangsberg
Journal:  Curr Infect Dis Rep       Date:  2004-10       Impact factor: 3.725

Review 2.  The HIV epidemic among individuals with mental illness in the United States.

Authors:  Sheri D Weiser; William R Wolfe; David R Bangsberg
Journal:  Curr HIV/AIDS Rep       Date:  2004-12       Impact factor: 5.071

3.  Prevalence and incidence of hepatitis B virus, hepatitis C virus and human immunodeficiency virus among personnel and patients of a psychiatric hospital.

Authors:  V Di Nardo; N Petrosillo; G Ippolito; M E Bonaventura; V Puro; B Chiaretti; M Tosoni
Journal:  Eur J Epidemiol       Date:  1995-04       Impact factor: 8.082

4.  Outcomes of a randomized small-group HIV prevention intervention trial for people with serious mental illness.

Authors:  L L Otto-Salaj; J A Kelly; L Y Stevenson; R Hoffmann; S C Kalichman
Journal:  Community Ment Health J       Date:  2001-04

Review 5.  Women with schizophrenia and co-occurring substance use disorders: an increased risk for violent victimization and HIV.

Authors:  J S Gearon; A S Bellack
Journal:  Community Ment Health J       Date:  1999-10

6.  Psychiatric and substance abuse comorbidity among HIV seropositive and HIV seronegative prisoners in Malaysia.

Authors:  Muhammad Muhsin Zahari; Woong Hwan Bae; Nor Zuraida Zainal; Hussain Habil; Adeeba Kamarulzaman; Frederick L Altice
Journal:  Am J Drug Alcohol Abuse       Date:  2010-01       Impact factor: 3.829

7.  SCREENING FOR AND PREVALENCE OF HIV AND HEPATITIS C AMONG AN OUTPATIENT URBAN SAMPLE OF PEOPLE WITH SERIOUS MENTAL ILLNESS AND CO-OCCURRING SUBSTANCE ABUSE.

Authors:  Seth Himelhoch; Richard Goldberg; Christine Calmes; Deborah Medoff; Eric Slade; Lisa Dixon; Gerard Gallucci; Stanley Rosenberg
Journal:  J Community Psychol       Date:  2011-02-02

8.  A multisite study of the prevalence of HIV with rapid testing in mental health settings.

Authors:  Michael B Blank; Seth S Himelhoch; Alexandra B Balaji; David S Metzger; Lisa B Dixon; Charles E Rose; Emeka Oraka; Annet Davis-Vogel; William W Thompson; James D Heffelfinger
Journal:  Am J Public Health       Date:  2014-02-13       Impact factor: 9.308

9.  Patterns, predictors and gender differences in HIV risk among severely mentally ill men and women.

Authors:  L L Otto-Salaj; T G Heckman; L Y Stevenson; J A Kelly
Journal:  Community Ment Health J       Date:  1998-04

10.  Access to HAART and utilization of inpatient medical hospital services among HIV-infected patients with co-occurring serious mental illness and injection drug use.

Authors:  Seth Himelhoch; Geetanjali Chander; John A Fleishman; James Hellinger; Paul Gaist; Kelly A Gebo
Journal:  Gen Hosp Psychiatry       Date:  2007 Nov-Dec       Impact factor: 3.238

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.